The limits of cost-effectiveness analysis

Circulation: Cardiovascular Quality and Outcomes

Volumn 2, Issue 1, 2009, Pages 55-58

  Weintraub, William S ^b   Cohen, David J ^a  

^a SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^b NONE

Author keywords

Cost benefit analysis; Cost effectiveness; Epidemiology; Outcomes

Indexed keywords

BOOTSTRAPPING; COST; COST EFFECTIVENESS ANALYSIS; ECONOMIC ASPECT; HEALTH CARE; HEALTH CARE UTILIZATION; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY CONTROL; RENAL REPLACEMENT THERAPY; SHORT SURVEY; STANDARDIZATION; ARTICLE; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH CARE COST; HEALTH SERVICES RESEARCH; REPRODUCIBILITY; STATISTICAL MODEL; TREATMENT OUTCOME; UNITED STATES;

COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HEALTH SERVICES RESEARCH; HUMANS; MODELS, ECONOMIC; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); QUALITY-ADJUSTED LIFE YEARS; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME; UNITED STATES;

EID: 63849280593     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.108.812321     Document Type: Short Survey

References (12)

1. Weintraub WS, Krumholz HM. Cost-effective strategies in cardiology. In: Fuster V, O'Rourke RA, Walsh RA, Poole-Wilson P, King SB III, Roberts R, Nash IS, Prystowsky EN, eds. Hurst's The Heart. 12 ed. New York, NY: McGraw Hill; 2008: 2417-2439.
2. Mahoney EM, Chu H. Cost-effectiveness analysis alongside clinical trials: statistical and methodologic issues. In: Weintraub WS, ed. Cardiovascular Health Care Economics. Totowa, NJ: Humana Press; 2003: 123-156.
3. Diamond GA, Kaul S. Cost, effectiveness, and cost-effectiveness. Circ Cardiovasc Qual Outcomes. 2009; 2: •••-•••.
4. Gold MR, Siegel JE, Russel LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996.
5. Nease RF Jr. Introduction to cost-effectiveness analysis. In: Weintraub WS, ed. Cardiovascular Health Care Economics. Totowa, NJ: Humana Press; 2003: 111-121.
6. Weintraub WS, Boden WE, Zhang Z, Kolm P, Spertus JA, Hartigan P, Veledar E, Jurkovitz C, Bowen J, Maron DJ, O'Rourke R, Dada M, Teo KK, Goeree R, Barnett PG. Cost-effectiveness of percutaneous coronary intervention in optimally-treated stable coronary patients. Circ Cardiovasc Qual Outcomes. 2008; 1: 12-20.
7. Hadorn DC. Setting health care priorities in Oregon: cost-effectiveness meets the rule of rescue. JAMA. 1991; 265: 2218-2225.
8. Borna S, Sundaram S. An approach to allocating limited health resources. J Health Soc Policy. 1999; 11: 85-94. (Pubitemid 29337205)
9. Garber AM, Phelps CE. Economic foundations of cost-effectiveness analysis. J Health Econ. 1997; 16: 1-31.
10. Tengs TO, Adams ME, Pliskin JS, Safran DG, Siegel JE, Weinstein MC, Graham JD. Five-hundred life-saving interventions and their costeffectiveness. Risk Anal. 1995; 15: 369-390.
11. Winkelmayer WC, Cohen DJ, Berger ML, Neumann PJ. Comparing cost-utility analyses in cardiovascular medicine. In: Weintraub WS, ed. Cardiovascular Health Care Economics. Totowa, NJ: Humana Press; 2003: 329-356.
12. Drummond MF, O'Brien B, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. Oxford, United Kingdom: Oxford Medical Publications; 1987.